Art

J-GLOBAL ID：201802231547745279   Reference number：18A0269745

Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pancreatic cancer

治癒切除された膵臓癌患者におけるゲムシタビンと自己γδT細胞移動によるアジュバント併用療法【Powered by NICT】

Author (7)： Aoki Taku (Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, The University of Tokyo, Tokyo, Japan) ,  Aoki Taku (Second Department of Surgery, Dokkyo Medical University, Mibu, Tochigi, Japan) ,  Matsushita Hirokazu (Department of Immunotherapeutics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan) ,  Hoshikawa Mayumi (Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, The University of Tokyo, Tokyo, Japan) ,  Hasegawa Kiyoshi (Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, The University of Tokyo, Tokyo, Japan) ,  Kokudo Norihiro (Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, The University of Tokyo, Tokyo, Japan) ,  Kakimi Kazuhiro (Department of Immunotherapeutics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan)
Material： Cytotherapy
Volume： 19  Issue： 4  Page： 473-485  Publication year： 2017 
JST Material Number： W1781A  ISSN： 1465-3249  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： The outcome for pancreatic can...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0269745&from=J-GLOBAL&jstjournalNo=W1781A") }}

Thesaurus term： university hospital ,  *pancreatic tumor ,  gastrointestinal disease ,  *patient ,  *combination therapy ,  quality ,  clinical trial ,  medical information ,  halogeno sugar ,  riboside
Semi thesaurus term： 無再発生存率 ,  骨髄抑制 ,  有害事象 ,  転帰 ,  *γδT細胞 ,  *治癒切除 , 【Automatic Indexing@JST】

Author keywords (5)： γδ T cell ,  adoptive transfer ,  pancreatic cancer ,  gemcitabine ,  adjuvant therapy

JST classification (2)： Tumors(=neoplasms)of digestive system  (GH04000D) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (1)： Gemcitabine

Terms in the title (8)： 治癒切除 ,  膵臓 ,  癌患者 ,  ゲムシタビン ,  自己 ,  γδT細胞 ,  アジュバント ,  併用療法